Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Role of Carbonic Anhydrase IX as Diagnostic and Theranostic Target in Von-hippel Lindau Disease

NCT07171905 is registered in ClinicalTrials.gov with IRCCS Ospedale San Raffaele as lead sponsor.

NCT NCT07171905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07171905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Role of Carbonic Anhydrase IX as Diagnostic and Theranostic Target in Von-hippel Lindau Disease
Lead sponsor
IRCCS Ospedale San Raffaele
Phase
Phase 2
Overall status
Recruiting
Start date
February 25, 2026
Completion date
December 31, 2026
Enrollment
38 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vhl - von hippel-lindau syndrome